mesalamine has been researched along with Necrosis in 5 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our understanding of coronavirus disease 2019 (COVID-19) and its implications for patients with inflammatory bowel diseases (IBD) is rapidly evolving." | 2.82 | COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. ( Godoy Brewer, G; Limketkai, BN; Parian, AM; Saleh Ismail, M; Sauk, JS; Singh, Y; Thu Nguyen, M; Tripathi, K, 2022) |
| "She was diagnosed with cutaneous polyarteritis nodosa (PAN) associated with CD." | 1.35 | Cutaneous polyarteritis nodosa in a patient with Crohn's disease. ( Kinoshita, K; Komatsuda, A; Maki, N; Masai, R; Niitsu, H; Ohtani, S; Sageshima, M; Sawada, K; Togashi, M; Wakui, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tripathi, K | 1 |
| Godoy Brewer, G | 1 |
| Thu Nguyen, M | 1 |
| Singh, Y | 1 |
| Saleh Ismail, M | 1 |
| Sauk, JS | 1 |
| Parian, AM | 1 |
| Limketkai, BN | 1 |
| López-Iñiguez, A | 1 |
| Pérez-Gutiérrez, MT | 1 |
| Lambraño-Castillo, D | 1 |
| Sierra-Madero, JG | 1 |
| Komatsuda, A | 1 |
| Kinoshita, K | 1 |
| Togashi, M | 1 |
| Maki, N | 1 |
| Masai, R | 1 |
| Niitsu, H | 1 |
| Ohtani, S | 1 |
| Sageshima, M | 1 |
| Sawada, K | 1 |
| Wakui, H | 1 |
| Matsumoto, T | 1 |
| Hayasaki, T | 1 |
| Nishimura, Y | 1 |
| Nakamura, M | 1 |
| Takeda, T | 1 |
| Tabuchi, Y | 1 |
| Obinata, M | 1 |
| Hanawa, T | 1 |
| Yamada, H | 1 |
| Beaulieu, S | 1 |
| Rocher, P | 1 |
| Hillion, D | 1 |
| Nochy, D | 1 |
| Tennenbaum, R | 1 |
| Vitte, RL | 1 |
| Eugène, C | 1 |
1 review available for mesalamine and Necrosis
| Article | Year |
|---|---|
COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Topics: Adrenal Cortex Hormones; COVID-19; Humans; Inflammatory Bowel Diseases; Mesalamine; Necrosis; Tumor | 2022 |
4 other studies available for mesalamine and Necrosis
| Article | Year |
|---|---|
Necrotic lesion in an immunosuppressed patient.
Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos | 2018 |
Cutaneous polyarteritis nodosa in a patient with Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Glucocort | 2008 |
Butyrate induces necrotic cell death in murine colonic epithelial cell MCE301.
Topics: Animals; Butyrates; Cells, Cultured; Colon; Intestinal Mucosa; Membrane Potentials; Mesalamine; Mice | 2006 |
[Acute tubular necrosis with acute renal failure during the first month of treatment with 5-amino-salicylate (Pentasa(R))].
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Kidney Tubules; | 2002 |